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cacy of the vaccine, it is needed to consider other factors that are
involved in occurrence of mumps outbreak.
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Background: In many countries, hepatitis A virus (HAV)
nfection has become an important public health issue with
mprovement in socioeconomic status. In Korea, a HAV vaccination
rogram for young adults has recently been under consideration
ecause of the low seroprotection rate in this age group.
To ensure long-term immunity, the vaccine manufacturers rec-
mmend2dosesof thevaccine, but in somecountries, a single-dose
AV vaccine is used for infants. The immunogenicity of the single-
ose HAV vaccine is a key factor for deciding the vaccination
chedule, but only a few studies have evaluated this immunogenic-
ty in adults.
This study was performed to examine the immunogenicity of
he single-dose HAV vaccine in young adults.
Methods: The study population comprised a total of 582 college
tudents from 8 medical schools in Korea. Total 451 participants
ho had negative results for anti-HAV antibody (cut-off value: 20
IU/ml) and met the inclusion criteria were randomly allocated
nto 2 groups for receiving either of the 2 vaccines: Havrix (n =225)
nd Epaxal (n =226) groups. We checked the seroconversion rate
t 7–12 months after vaccination.
Results: The seroconversion rate in Havrix group (84.9%) was
igniﬁcantly higher than that in Epaxal group (76.5%; P =0.031),
nd the male participants (75.3%) showed signiﬁcantly lower sero-
onversion rates than the female participants (91.4%; P <0.001). In
he logistic regression model, only gender was a statistically signif-
cant factor affecting seroconversion rates (OR= 2.7, P =0.016) and
accine type showed borderline signiﬁcance (OR=1.6, P =0.051).
he other covariates (follow-up time, age, and body weight) were
ot signiﬁcant. In the logistic regression model analysis according
o the vaccine type, gender showed a signiﬁcant effect only in the
paxal group (OR=5.0, P =0.011).
Conclusion: After single-dose vaccination, the HavrixTM and
paxal® vaccines showed immunogenicity of more than 75.0%
t 7–12 months after the vaccination, and the male participants
howed lower seroconversion rates than the female participants,
articularly in the Epaxal group. The seroconversion rate after the
econd dose and the long-term immunogenicity will be compared
or the 2 vaccine types in future studies.fectious Diseases 16S (2012) e158–e316
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Background:Althoughmumps is a vaccine-preventable disease
and mumps vaccine has more than 95% of its vaccination rate as a
component of MMR vaccine, disease occurrence is continued. We
aimed to assess the effectiveness of the mumps component of the
MMR vaccine.
Methods: This study evaluated the efﬁcacy of mumps vaccine
through the prospective and retrospective case-control studies in
four university hospitals. Another achievement is to establish the
mumps virus RT-PCR assays for diagnosis in the research team.
Results: In prospective case-control study, 55 cases of mumps
were identiﬁed and 165 controls were selected from March 2010
to October 2011. Data about their demographic characteristics and
MMR vaccination status were collected in cases and controls. Risk
for disease estimated by conditional logistic analysis is OR 0.67
(95%CI 0.06-7.35) in vaccinated that is lower than innonvaccinated.
Risk for mumps is OR 0.58 (95%CI 0.05-6.90) for 1 dose and OR
1.10 (95% CI 0.09-13.31) for 2 doses. In retrospective studies, 122
cases of mumps were identiﬁed and 449 controls were selected. In
2008-2009 in western Seoul, Incheon and Goyang, an outbreak of
mumps occurred among children most of whom were born before
1994. 98% of cases whose vaccination status were available had a
history at least one MMR vaccination. Estimated risk for disease is
OR 0.33 (95% CI 0.02-5.33) in vaccinated that is lower than in non-
vaccinated. Risk for mumps is OR 0.33 (95% CI 0.02-5.33) for 1 dose
and OR 0.11 (95% CI 0.01-2.12) for 2 doses. And, we analyzed data
collected in the prospective and retrospective study. Estimated risk
for disease is OR 0.50 (95% CI 0.08-2.99) in vaccinated that is lower
than innonvaccinated. Risk formumps isOR0.58 (95%CI 0.10-3.56)
for 1 dose and OR 0.42 (95% CI 0.06-2.81) for 2 doses.
Conclusion:Mumps vaccine hadpreventive effect and twodose
vaccination had superior effect than one dose, even though there
was no statistically signiﬁcant difference. In addition to the efﬁ-
